Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results
出版年份 2023 全文链接
标题
Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results
作者
关键词
-
出版物
NATURE MEDICINE
Volume 29, Issue 4, Pages 898-905
出版商
Springer Science and Business Media LLC
发表日期
2023-04-04
DOI
10.1038/s41591-022-02170-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The multiple roles of LDH in cancer
- (2022) Giuseppina Claps et al. Nature Reviews Clinical Oncology
- Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety, and cerebrospinal fluid biomarkers
- (2021) Jarushka Naidoo et al. Journal for ImmunoTherapy of Cancer
- Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma
- (2021) Jedd D. Wolchok et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study
- (2021) Hussein A Tawbi et al. LANCET ONCOLOGY
- Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis
- (2021) Priscilla K. Brastianos et al. Nature Communications
- Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases (BTIP-BM)
- (2020) Timothy J Kaufmann et al. NEURO-ONCOLOGY
- Leptomeningeal disease in melanoma patients: An update to treatment, challenges, and future directions
- (2020) Isabella C. Glitza et al. Pigment Cell & Melanoma Research
- Survival of patients with advanced metastatic melanoma: The impact of MAP kinase pathway inhibition and immune checkpoint inhibition - Update 2019
- (2020) Selma Ugurel et al. EUROPEAN JOURNAL OF CANCER
- Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis
- (2020) Priscilla K. Brastianos et al. NATURE MEDICINE
- Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAFV600 mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial
- (2020) Ralf Gutzmer et al. LANCET
- Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD)
- (2019) Sherise D. Ferguson et al. JOURNAL OF NEURO-ONCOLOGY
- Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study
- (2018) Georgina V Long et al. LANCET ONCOLOGY
- Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
- (2018) Hussein A. Tawbi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Term Survival of Patients With Melanoma With Active Brain Metastases Treated With Pembrolizumab on a Phase II Trial
- (2018) Harriet M. Kluger et al. JOURNAL OF CLINICAL ONCOLOGY
- Enzyme linked immunosorbent assay for the quantification of nivolumab and pembrolizumab in human serum and cerebrospinal fluid
- (2018) Dick Pluim et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Melanoma central nervous system metastases: current approaches, challenges, and opportunities
- (2016) Justine V. Cohen et al. Pigment Cell & Melanoma Research
- Intrathecal Administration of Tumor-Infiltrating Lymphocytes Is Well Tolerated in a Patient with Leptomeningeal Disease from Metastatic Melanoma: A Case Report
- (2015) I. C. Glitza et al. Cancer Immunology Research
- A retrospective case series of 103 consecutive patients with leptomeningeal metastasis and breast cancer
- (2013) E. Le Rhun et al. JOURNAL OF NEURO-ONCOLOGY
- Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial
- (2012) Kim Margolin et al. LANCET ONCOLOGY
- Clinicopathological features of breast cancers predict the development of leptomeningeal metastases: a case-control study
- (2011) Emilie Le Rhun et al. JOURNAL OF NEURO-ONCOLOGY
- Role of Intrathecal Rituximab and Trastuzumab in the Management of Leptomeningeal Carcinomatosis
- (2010) Anthony J Perissinotti et al. ANNALS OF PHARMACOTHERAPY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started